Carlos Bustamante joined F-Prime Capital in January 2019 as a Venture Partner based in Silicon Valley, California and is focused on the application of data science and genomics technology to problems in medicine, agriculture, and biology. He is currently on leave from Stanford University where he is a Professor of Biomedical Data Science, Genetics, and (by courtesy) Biology, was founding Director of the Stanford Center for Computational, Evolutionary, and Human Genomics and is Inaugural Chair of the Department of Biomedical Data Science.
Carlos has a passion for building new academic units, non-profits, and companies to solve pressing scientific challenges. He is currently a Director at EdenRoc Sciences, LLC and Etalon DX, founder of Arc Bio, LLC and CDB Consulting LTD., and has served as an SAB member for more than a dozen companies.
Carlos received his Ph.D. in Biology and MS in Statistics from Harvard University.
Singular Genomics (NASDAQ: OMIC) is developing a new next generation sequencing platform. Learn more at www.singulargenomics.com.